HPS Pharmacies wish to give notice that Mundipharma is experiencing a supply interruption for Dilaudid® tablets as follows:

Dilaudid® Tablets
Hydromorphone hydrochloride 2mg
ARTG 67353 

Dilaudid® Tablets
Hydromorphone hydrochloride 4mg
ARTG 67354 

Normal supplies are expected to resume by end-March 2022. HPS Pharmacies has sourced an internationally registered alternative that may be accessed via the Special Access Scheme (SAS), if necessary. Please note that SAS alternatives are subject to a longer lead-time and different pricing as they must be sourced internationally.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Mundipharma on 1800 188 009 or your pharmacist at HPS Pharmacies.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates